Professional
Added to YB: 2024-10-24
Pitch date: 2024-09-30
FRE.DE [bullish]
Fresenius SE & Co. KGaA
+43.91%
current return
Author Info
No bio for this author
Company Info
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa.
Market Cap
EUR 26.6B
Pitch Price
EUR 32.40
Price Target
N/A
Dividend
2.23%
EV/EBITDA
11.05
P/E
16.99
EV/Sales
1.61
Sector
Health Care Providers and Services
Category
value
Oakmark International Strategy Portfolio Holding: Fresenius SE & Co. KGaA
FRE.DE: Strong Q2 results, esp. Kabi's biosimilars (Tyenne) & Helios' growth in Spain. Mgmt focus on ops execution & portfolio simplification. Attractively valued. Health care services co. w/ leading hospital ops in Europe. Encouraging subsidiary update. Stock rose on positive performance.
Read full article (1 min)